PGR and breast cancer: The molecular or immunohistochemical investigation enabled the classification of BC into four principal subtypes based on the estrogen receptor (ER), progesterone receptor (PgR), human epidermal growth factor receptor 2 (HER2) and Ki67 expression [5].